3,279 results match your criteria: "Research Center for Translational Medicine[Affiliation]"

Urinary Proteomics and Systems Biology Link Eight Proteins to the Higher Risk of Hypertension and Related Complications in Blacks Versus Whites.

Proteomics

November 2024

Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Blacks are more prone to salt-sensitive hypertension than Whites. This cross-sectional analysis of a multi-ethnic cohort aimed to search for proteins potentially involved in the susceptibility to salt sensitivity, hypertension, and hypertension-related complications. The study included individuals enrolled in African Prospective Study on the Early Detection and Identification of Cardiovascular Disease and Hypertension (African-PREDICT), Flemish Study of the Environment, Genes and Health Outcomes (FLEMENGHO), Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID)-Austria, and Urinary Proteomics Combined with Home Blood Pressure Telemonitoring for Health Care Reform Trial (UPRIGHT-HTM).

View Article and Find Full Text PDF

Effect of therapeutic erythrocytapheresis on outcomes and renal benefit in patients with high-altitude polycythemia: a real-world study.

Sci Rep

November 2024

Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital, National Research Center for Translational Medicine at Shanghai, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Kidney injury from high-altitude polycythemia (HAPC) is common, yet few studies have explored effective treatments. This research assessed the renal benefits of therapeutic erythrocytapheresis (TE) in HAPC patients, analyzing the efficacy of single versus multiple treatments. From 2017 to 2023, 631 patients undergoing TE were included.

View Article and Find Full Text PDF

Diabetes in China part 2: prevention, challenges, and progress.

Lancet Public Health

December 2024

Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center for Metabolic Diseases (Shanghai), Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, National Research Center for Translational Medicine, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:

During the past 40 years, the prevalence of diabetes in China has increased from less than 1·0% in 1980 to 12·4% in 2018, an increase in line with the rapid growth of the nation's economy. To address such a burden, the Healthy China 2030 initiative and subsequent Action Plan, including a diabetes prevention and control campaign, were launched. A shift from a disease-centred approach to a health-centred approach and from treatment to prevention is the core of the Action Plan and diabetes management in China.

View Article and Find Full Text PDF

Diabetes in China part 1: epidemiology and risk factors.

Lancet Public Health

December 2024

Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center for Metabolic Diseases (Shanghai), Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, National Research Center for Translational Medicine, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:

The prevalence of diabetes in China is rapidly increasing. China now has the largest number of people living with diabetes worldwide, accounting for approximately one-quarter of the global diabetes population. Since the late 1970s, China has experienced profound changes and rapid economic growth, leading to shifts in lifestyle.

View Article and Find Full Text PDF

Objective: The purpose of this study was to determine the efficacy and safety of combined intravenous and topical use of tranexamic acid (TXA) in patients undergoing separation surgery for thoracolumbar spinal metastases by evaluating perioperative blood loss and complications.

Methods: A total of 54 patients with thoracolumbar spinal metastases who received separation surgery in our hospital from 2021 to 2024 were retrospectively analyzed and divided into 3 groups according to the use of TXA. Combined use of TXA group (group A) included 20 patients, intravenous TXA group (group B) contained 18 patients, and 16 cases received no TXA .

View Article and Find Full Text PDF

Emergence of carbapenem resistance in persistent Shewanella algae bacteremia: the role of pdsS G547W mutation in adaptive subpopulation dynamics.

Ann Clin Microbiol Antimicrob

November 2024

Division of Infectious Diseases, Department of Internal Medicine, Taichung Veterans General Hospital, 1650, Section 4, Taiwan Blvd, Xitun District, Taichung, 40705, Taiwan.

Article Synopsis
  • - This study investigates genetic mechanisms behind the rising resistance of Shewanella algae to carbapenem antibiotics, focusing on the evolutionary changes that occur in response to treatment.
  • - Researchers used advanced sequencing techniques to monitor a specific mutation (G547W) linked to increased expression of a protein that aids in resistance, demonstrating how bacterial populations can shift rapidly in response to antibiotic exposure.
  • - The findings highlight how some resistant cells can exist even without antibiotics and suggest that these hidden populations contribute to resistance development during treatment, revealing complex interactions that influence medical outcomes.
View Article and Find Full Text PDF

Patients with schizophrenia with early onset age have been shown to exhibit more severe negative symptoms. Genetic, biomarker, postmortem brain, and imaging studies indicate the involvement of immune abnormalities in the pathophysiology of schizophrenia. In this study, we examined the moderating role of early onset on the associations between clinical symptoms and neutrophil-to-lymphocyte ratio (NLR) in medication-naïve first-episode schizophrenia (MNFES).

View Article and Find Full Text PDF

Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD.

Neurology

December 2024

From the Department of Neuroscience (P.S., A.V.D.W., P.G.S., Y.C.F., W.Z.Y., C.Z., V.G.J., H.B., M.M.), Central Clinical School, Monash University, Melbourne, Victoria; Department of Neurology (P.S., A.V.D.W., P.G.S., Y.C.F., W.Z.Y., V.G.J., H.B., M.M.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology (P.S., S.H.), Walton Centre NHS Foundation Trust, Liverpool, United Kingdom; Neuroimmunology Centre (S.S., I.R., T.K.), Department of Neurology, The Royal Melbourne Hospital, Parkville; CORe (S.S., I.R., T.K.), Department of Medicine, University of Melbourne, Victoria; Royal Hobart Hospital (Y.C.F.), Hobart, Tasmania, Australia; Nehme and Therese Tohme Multiple Sclerosis Center (S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon; Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary; Department of Neurology (B.W.), Antwerp University Hospital, Edegem; Translational Neurosciences Research Group (B.W.), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium; Faculty of Medicine (M.E.), Isfahan University of Medical Sciences; Neurology (M.E.), Dr. Etemadifar MS Institute, Isfahan, Iran; Izmir University of Economics (S.O.), Medical Point Hospital; Multiple Sclerosis Research Association (S.O.), Izmir, Turkey; Department of Neurology and Center of Clinical Neuroscience (P.N., D.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic; Department of Neurology (A.A.), School of Medicine and Koc University Research Center for Translational Medicine (KUTTAM), Koc University, Istanbul, Turkey; College of Medicine & Health Sciences and Sultan Qaboos University Hospital (A.A.-A.), Sultan Qaboos University, Al-Khodh, Oman; Department of Neuroscience (C.M.R.-T.), Hospital Germans Trias I Pujol, Badalona, Spain; Department of Neurology (G.L.), University Hospital Ghent, Belgium; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy; Multiple Sclerosis Unit (F.P.), AOU Policlinico G Rodolico-San Marco, University of Catania; Department of Neuroscience (M.F.), MS Center, Neurology Unit, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy; Department of Biotechnological and Applied Clinical Sciences (DISCAB) (M.F.), University of L'Aquila, Italy; Department of Neurology (C.B.), Karadeniz Technical University, Medical Faculty, Trabzon, Turkey; Department of Neurology (P.A.M.), Royal Brisbane Hospital; University of Queensland (P.A.M.), Australia; Department of Neurology (R.T.), Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey; Hunter Medical Research Institute (J.L.-S.), Neurology, University of Newcastle; and Hunter New England Health (J.L.-S.), John Hunter Hospital, New South Wales, Australia.

Article Synopsis
  • The study investigated the prevalence of two types of disability progression in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD): Progression Independent of Relapse Activity (PIRA) and Relapse-Associated Worsening (RAW).
  • It included 181 patients from the MSBase registry, mostly females with an average age of 38.1 years, monitored for an average of 4.5 years, where only 2.2% experienced PIRA and 7.2% experienced RAW.
  • The findings suggest PIRA is rare in AQP4-IgG NMOSD cases, but the study had limitations, such as using
View Article and Find Full Text PDF

scPharm: Identifying Pharmacological Subpopulations of Single Cells for Precision Medicine in Cancers.

Adv Sci (Weinh)

January 2025

Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.

Intratumour heterogeneity significantly hinders the efficacy of anticancer therapies. Compared with drug perturbation experiments, which yield pharmacological data at the bulk cell level, single-cell RNA sequencing (scRNA-seq) technology provides a means to capture molecular heterogeneity at single-cell resolution. Here, scPharm is introduced, a computational framework that integrates pharmacological profiles with scRNA-seq data to identify pharmacological subpopulations of cells within a tumour and prioritize tailored drugs.

View Article and Find Full Text PDF

Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.

N Engl J Med

November 2024

From the Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, and the National Clinical Research Center for Metabolic Diseases (Shanghai), Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the People's Republic of China, National Research Center for Translational Medicine, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics (Y.B., M.L., J.L., T.W., R.Z., Y.C., M.X., S.W., J.N., Z.Z., J.D., G.N., Y.X., W.W.), the Lifecycle Health Management Center (Jingya Wang), and the Ruijin-Junshi Clinical Research Center (L.L.), Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and the School of Clinical Medicine, Shanghai University of Medicine and Health Sciences (J.N.), Shanghai, the Department of Endocrine and Metabolic Diseases, Third People's Hospital of Datong (Y.L.), and the Department of Endocrine and Metabolic Diseases, Heji Hospital Affiliated to Changzhi Medical College (X.N.), Shanxi, the Department of Endocrine and Metabolic Diseases, First People's Hospital of Loudi (T.L.), and the Department of Endocrine and Metabolic Diseases, People's Hospital of Liuyang (X.Q.), Hunan, the Department of Endocrine and Metabolic Diseases, Third Hospital of Nanchang, Jiangxi (P.D.), the Department of Endocrine and Metabolic Diseases, General Hospital of Hebi Coal Industry Group (F.X.), the Department of Endocrine and Metabolic Diseases, People's Hospital of Zhengzhou (Q.D.), the Department of Endocrine and Metabolic Diseases, People's Hospital of Anyang City (X.W.), the Department of Endocrine and Metabolic Diseases, Zhengzhou Central Hospital (Z.K.), and the Department of Endocrine and Metabolic Diseases, General Hospital of Pingmei Shenma Group (H.Z.), Henan, the Department of Endocrine and Metabolic Diseases, Yankuang New Journey General Hospital (Ailiang Wang), the Department of Endocrinology, Second Affiliated Hospital of Shandong First Medical University (Xinhuan Zhang), the Department of Endocrine and Metabolic Diseases, Weifang Municipal Official Hospital (Jing Wang), the Department of Endocrine and Metabolic Diseases, Jinan Central Hospital Affiliated to Shandong First Medical University (S.P.), the Department of Endocrine and Metabolic Diseases, Weifang Hi-tech Zone People's Hospital (Xiaoliang Zhang), the Department of Endocrine and Metabolic Diseases, Second Hospital of Shandong University (S.C.), and the Department of Endocrine and Metabolic Diseases, Shanghe County People's Hospital (Z.G.), Shandong, the Department of Endocrine and Metabolic Diseases, Tieli People's Hospital (Y.N.), the Department of Endocrine and Metabolic Diseases, Yian County Hospital of Traditional Chinese Medicine (C.L.), and the Department of Endocrine and Metabolic Diseases, Wuchang People's Hospital (W.T.), Heilongjiang, the Department of Endocrine and Metabolic Diseases, Anqing Shihua Hospital of Nanjing Drum Tower Hospital Group (An Wang), and the Department of Endocrine and Metabolic Diseases, Lai'an Jia Ning Hospital (S.D.), Anhui, the Department of Cardiology, Zhongshan Hospital, Fudan University (Xiamen branch), Fujian (S.W.), the Department of Endocrine and Metabolic Diseases, Jilin Municipal People's Hospital (H.P.), and the Department of Endocrine and Metabolic Diseases, First Hospital of Jilin University (G.W.), Jilin, the Department of Endocrine and Metabolic Diseases, Hai'an People's Hospital (X.Y.), and the Department of Endocrine and Metabolic Diseases, Sheyang County Diabetes Hospital (Y.D.), Jiangsu, the Department of Endocrine and Metabolic Diseases, Affiliated Hospital of Southwest Medical University, Sichuan (Q.W.), the Department of Endocrine and Metabolic Diseases, Yuhuan Second People's Hospital, Zhejiang (Q.Z.), and the Department of Endocrine and Metabolic Diseases, Second Hospital of Dalian Medical University, Liaoning (H.L.) - all in China; and the O'Donnell School of Public Health, University of Texas Southwestern Medical Center, Dallas (J.H.).

Article Synopsis
  • A study was conducted to find out the best systolic blood pressure targets for patients over 50 with type 2 diabetes and high cardiovascular risk, comparing intensive treatment (target <120 mm Hg) to standard treatment (target <140 mm Hg) over 5 years.
  • Out of 12,821 patients, the intensive treatment group had a lower average systolic blood pressure after one year (121.6 mm Hg) compared to the standard group (133.2 mm Hg), resulting in significantly fewer major cardiovascular events.
  • Despite the lower overall events in the intensive group, there were more cases of symptomatic hypotension and hyperkalemia, but the rates of serious adverse events were similar in both groups.
View Article and Find Full Text PDF

The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy.

Front Immunol

November 2024

Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital, School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.

Introduction: Immunogenic cell death (ICD) is capable of activating the anti-tumor immune response of the organism; however, it is concurrently a complex process involving multiple factors. The specific factors that impact the occurrence of ICD remain undefined.

Methods: Through cluster analysis, patient specimens retrieved from the TARGET, TCGA, and GEO AML databases were categorized into two subtypes based on the expression levels of ICD-related genes: ICD-high and ICD-low.

View Article and Find Full Text PDF

The modulation of gut microbiota through probiotics holds promise as a novel avenue for schizophrenia treatment. This study aims to analyze probiotic complementary therapy on individuals with schizophrenia systematically, to investigate probiotic efficacy, potential mechanisms, and implications for clinical practice. Adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched in Medline, Web of Science, Embase, ClinicalTrials.

View Article and Find Full Text PDF

Single-cell RNA sequencing reveals the landscape of the cellular ecosystem of primary hepatocellular carcinoma.

Cancer Cell Int

November 2024

Engineering Research Center for New Materials and Precision Treatment Technology of Malignant Tumors Therapy, The Second Affiliated Hospital, Dalian Medical University, 467 Zhongshan Road, Dalian, 116023, Liaoning, China.

Article Synopsis
  • HCC is a complex ecosystem involving cancer cells and various nonmalignant cells, which interact dynamically to promote tumor growth and treatment resistance.
  • The use of single-cell RNA sequencing (scRNA-seq) allows for detailed analysis of cell types, their diversity, and interactions within HCC, aiding in understanding its complexity.
  • This review focuses on scRNA-seq findings in treatment-naive primary HCC, detailing cell composition, molecular subtypes, and interactions within the tumor microenvironment.
View Article and Find Full Text PDF

A cost-effective protocol for single-cell RNA sequencing of human skin.

Front Immunol

November 2024

Koç University Research Center for Translational Medicine, Koç University, Istanbul, Türkiye.

Article Synopsis
  • Single-cell RNA sequencing (scRNAseq) and flow cytometry in skin research are expensive and complex, often limiting their use for researchers, particularly when analyzing both RNA and protein from the same samples.* -
  • The study introduces a new sample multiplexing strategy that allows for simultaneous scRNAseq and flow cytometry on paired blood and skin samples, enhancing data collection and analysis across healthy and inflamed specimens.* -
  • This novel approach not only cuts costs by 2-4 times and reduces technical issues but also includes detailed protocols for implementation, making advanced skin analysis techniques more accessible for researchers.*
View Article and Find Full Text PDF

The relationship between cumulative family risk and depression in left-behind children: a moderated mediation model.

BMC Psychol

November 2024

Department of Psychology, The School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, China.

Background: This study proposed a moderated mediation model to examine the mediating role of core self-evaluation in the relationship between cumulative family risk and depression among left-behind children, and whether this process was moderated by school climate.

Methods: A total of 415 rural left-behind children from 35 townships in Anhui Province (54.46% males; mean age = 12.

View Article and Find Full Text PDF
Article Synopsis
  • Dilated cardiomyopathy (DCM) is a serious heart condition linked to high mortality rates, and mutations in the lamin A/C gene are a common cause, with few treatment options available.
  • Researchers created a mouse model with this mutation and observed cardiac dysfunction starting at one month old, along with mitochondrial damage and reduced SIRT1 levels in younger hearts.
  • Overexpressing SIRT1 improved mitochondrial function and reduced heart damage, suggesting that targeting the SIRT1 pathway could offer new treatment possibilities for DCM related to lamin A/C mutations.
View Article and Find Full Text PDF

The blood enzyme glutamate-oxaloacetate transaminase (GOT) has been postulated as an effective therapeutic to protect the brain during stroke. To demonstrate its potential clinical utility, a new human recombinant form of GOT (rGOT) was produced for medical use. We tested the pharmacokinetics and evaluated the protective efficacy of rGOT in rodent and non-human primate models that reflected clinical stroke conditions.

View Article and Find Full Text PDF
Article Synopsis
  • Pituitary adenomas (PAs) are common brain tumors where the TRIM family, especially TRIM21, is linked to increased cell growth and resistance to therapies, though its specific role in PAs needs further exploration.
  • CRISPR screening and various experiments revealed that TRIM21 enhances cell proliferation and drug resistance in PAs by interacting with ERK1/2, ultimately affecting its activity through ubiquitination.
  • Targeting TRIM21 shows potential benefits in treating PAs, as reducing its levels with drugs like Fimepinostat and Quisinostat could inhibit tumor growth and improve response to existing treatments.
View Article and Find Full Text PDF

Aim: This pre-post intervention study aimed to assess the relationship between baseline dietary quality and the efficacy of a dietitian-guided weight reduction program, which has not been thoroughly documented to date.

Methods: Ninety-two consecutive obese or overweight patients visiting a tertiary center clinic for weight reduction were enrolled in this study. Participants received a dietitian-guided weight reduction education program aimed at reducing daily caloric intake by 500 kcal and improving adherence to the Mediterranean diet for 3 months.

View Article and Find Full Text PDF

Reevaluating the energy cost in locomotion: quadrupedal vs. bipedal walking in humans.

Int J Sports Med

January 2025

Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

This study examines the energy expenditure and physiological responses associated with short-term quadrupedal locomotion compared to bipedal walking in humans. It aims to support evolutionary theory and explore quadrupedal locomotion's potential for enhancing fitness and health. In a randomized crossover design, 12 participants performed quadrupedal and bipedal walking on a treadmill at identical speeds.

View Article and Find Full Text PDF

Association of High-Risk Obstructive Sleep Apnea with Artificial Intelligence-Guided, CT-Based Severity Scores in Patients with COVID-19 Pneumonia.

J Clin Med

October 2024

Department of Pulmonary Medicine, Koc University School of Medicine, and Koc University Research Center for Translational Medicine (KUTTAM), Koc University, Istanbul 34010, Türkiye.

We have previously demonstrated that high-risk obstructive sleep apnea (HR-OSA), based on a modified Berlin Questionnaire (mBQ), is linked to worse clinical outcomes. Chest computed tomography (CT) imaging with the implementation of an artificial intelligence (AI) analysis program has been a valuable tool for the speedy assessment of huge numbers of patients during the COVID-19 epidemic. In the current study, we addressed how the severity of AI-guided, CT-based total opacity ratio (TOR) scores are associated with high-risk OSA and short-term outcomes in the same cohort.

View Article and Find Full Text PDF

Raising the Bar: Progress in 3D-Printed Hybrid Bone Scaffolds for Clinical Applications: A Review.

Cell Transplant

November 2024

Department of Interventional and Vascular Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

Damage to bones resulting from trauma and tumors poses a significant challenge to human health. Consequently, current research in bone damage healing centers on developing three-dimensional (3D) scaffolding materials that facilitate and enhance the regeneration of fractured bone tissues. In this context, the careful selection of materials and preparation processes is essential for creating demanding scaffolds for bone tissue engineering.

View Article and Find Full Text PDF

PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia.

Nat Commun

November 2024

Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

The epigenetic landscape plays a critical role in cancer progression, yet its therapeutic potential remains underexplored. Glucocorticoids are essential components of treatments for lymphoid cancers, but resistance, driven in part by epigenetic changes at glucocorticoid-response elements, poses a major challenge to effective therapies. Here we show that glucocorticoid treatment induces distinct patterns of chromosomal organization in glucocorticoid-sensitive and resistant acute lymphoblastic leukemia xenograft models.

View Article and Find Full Text PDF
Article Synopsis
  • Immune system activation and lipotoxicity from lipid droplet buildup are significant contributors to the development of Nonalcoholic Steatohepatitis (NASH).
  • The study examined platelet-derived extracellular vesicles (pEVs) from patients with varying severity of nonalcoholic fatty liver disease and found increased platelet activation and dysfunctional mitochondria associated with pEVs in those with NASH.
  • The findings suggest a new link between platelets, pEVs, and lipid droplet accumulation, indicating that reducing pEV production or their uptake might help slow down NASH progression, though further research is needed.
View Article and Find Full Text PDF

Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma: The FUMANBA-1 Nonrandomized Clinical Trial.

JAMA Oncol

November 2024

National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Importance: Equecabtagene autoleucel (eque-cel), a fully human-derived B-cell maturation antigen-targeting chimeric antigen receptor (CAR) T-cell therapy, has exhibited potential for the treatment of relapsed or refractory multiple myeloma (RRMM), and further investigation in a larger cohort is necessary.

Objective: To evaluate whether eque-cel can benefit patients with RRMM and determine the overall response rate postinfusion.

Design, Setting, And Participants: The FUMANBA-1 trial was a single-arm, open-label, phase 1b/2 trial that evaluated eque-cel in adult patients with RRMM.

View Article and Find Full Text PDF